Compare MIST & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIST | LANV |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | Canada | China |
| Employees | N/A | 2066 |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 178.9M |
| IPO Year | 2019 | N/A |
| Metric | MIST | LANV |
|---|---|---|
| Price | $1.27 | $1.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 11.1K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | $3.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $1.03 |
| 52 Week High | $3.06 | $2.62 |
| Indicator | MIST | LANV |
|---|---|---|
| Relative Strength Index (RSI) | 43.24 | 39.06 |
| Support Level | $1.20 | $1.03 |
| Resistance Level | $1.42 | $1.79 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 40.00 | 1.96 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the St. John segment.